Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Doecke

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 30, 2022
Plasma p-tau181/Aβ<sub>1-42</sub> ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ<sub>1-42</sub> and future cognitive declineChristopher J Fowler, Erik Stoops, Stephanie R Rainey-Smith, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of agingVeer Bala Gupta, James D Doecke, Eugene Hone, et al.
Journal of Alzheimer'S Disease : JAD|May 3, 2021
Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older AdultsSamantha L Gardener, Michael Weinborn, Hamid R Sohrabi, et al.
Journal of Crohn'S & Colitis|March 13, 2012
Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian studyKrupa Krishnaprasad, Jane M Andrews, Ian C Lawrance, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Communications Medicine|February 27, 2025
Alzheimer's disease biological PET staging using plasma p217+tauAzadeh Feizpour, Vincent Doré, Natasha Krishnadas, et al.
Journal of Proteome Research|January 18, 2024
Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain RegionsMelanie T Odenkirk, Xueyun Zheng, Jennifer E Kyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adultsMichael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Clinical Biochemistry|May 27, 2019
Elecsys<sup>®</sup> Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluidValeria Lifke, Gwendlyn Kollmorgen, Ekaterina Manuilova, et al.
Inflammatory Bowel Diseases|January 26, 2013
Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's diseaseJames D Doecke, Lisa A Simms, Zhen Zhen Zhao, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 30, 2022
Plasma p-tau181/Aβ<sub>1-42</sub> ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ<sub>1-42</sub> and future cognitive declineChristopher J Fowler, Erik Stoops, Stephanie R Rainey-Smith, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of agingVeer Bala Gupta, James D Doecke, Eugene Hone, et al.
Journal of Alzheimer'S Disease : JAD|May 3, 2021
Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older AdultsSamantha L Gardener, Michael Weinborn, Hamid R Sohrabi, et al.
Journal of Crohn'S & Colitis|March 13, 2012
Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian studyKrupa Krishnaprasad, Jane M Andrews, Ian C Lawrance, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Communications Medicine|February 27, 2025
Alzheimer's disease biological PET staging using plasma p217+tauAzadeh Feizpour, Vincent Doré, Natasha Krishnadas, et al.
Journal of Proteome Research|January 18, 2024
Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain RegionsMelanie T Odenkirk, Xueyun Zheng, Jennifer E Kyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adultsMichael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Clinical Biochemistry|May 27, 2019
Elecsys<sup>®</sup> Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluidValeria Lifke, Gwendlyn Kollmorgen, Ekaterina Manuilova, et al.
Inflammatory Bowel Diseases|January 26, 2013
Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's diseaseJames D Doecke, Lisa A Simms, Zhen Zhen Zhao, et al.
Pageof 12